Volume 80, Issue 5 (August 2022)
Tehran Univ Med J 2022, 80(5): 414-419 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Asgharpour M, Ezoji K, Akbari R, Latifi K, Seyfi S. Covid-19 infection in kidney transplant recipients: a case report. Tehran Univ Med J 2022; 80 (5) :414-419
URL: http://tumj.tums.ac.ir/article-1-11865-en.html
URL: http://tumj.tums.ac.ir/article-1-11865-en.html
1- Department of Internal Medicine, Clinical Research Development Unit of Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babal, Iran.
2- Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babal, Iran.
3- Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran.
4- Department of Anesthesiology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
5- Department of Anesthesiology, Clinical Research Development, Unit of Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
2- Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babal, Iran.
3- Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran.
4- Department of Anesthesiology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
5- Department of Anesthesiology, Clinical Research Development, Unit of Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Abstract: (934 Views)
Background: Information on the coronavirus infection 2019 (COVID-19) which can clinically range from asymptomatic infection to severe pneumonia, in transplant recipients is still low. Infections are a major cause of death in kidney transplant recipients, and kidney transplant recipients, like other organ recipients, appear to be more vulnerable to a variety of infections due to comorbidities and immunosuppressive drugs that predispose them to infection.
Case presentation: In this study, we reviewed 10 transplant recipients with a mean age of 50.3±11.25 years who were admitted to Ayatollah Rouhani Hospital in Babol due to COVID-19 From April 2019 to September 2019. Four patients were female and six ones were male. Fever (100%) and cough (60%) were the most common symptoms in patients. All patients used standard immunosuppressive drugs (tacrolimus, corticosteroids, mycophenolate, and cyclosporine). The mean level of oxygen saturation at the time of admission in these patients was 87.9±11.3 and in two patients with death outcomes of 57% and 95%, it was at the beginning of hospitalization. The mean leukocytes of patients at the beginning of hospitalization was10470±5784.08 per ml and the mean lymphocytes of these patients were 1081.5±516.05. In the studied patients, the mean of previous years of transplantation was 8/05±7.13 and two patients died 20 years and 5 years after their kidney transplantation. Two patients (20%), aged 57 and 50 years, died from progressive respiratory symptoms and the other eight patients recovered and were discharged from the hospital.
We reported COVID-19 infection in ten kidney transplant recipients with different clinical outcomes and periods, which may be a reference for the management of COVID-19 in such patients.
Conclusion: It seems that more information is needed to better understand the effect of anti-transplant immunosuppressive therapy on the outcome of COVID-19 infection in kidney transplant recipients. Long-term follow-up studies and more cases are needed to clarify the diagnosis, outcome, and treatment options for COVID-19 in these patients.
Case presentation: In this study, we reviewed 10 transplant recipients with a mean age of 50.3±11.25 years who were admitted to Ayatollah Rouhani Hospital in Babol due to COVID-19 From April 2019 to September 2019. Four patients were female and six ones were male. Fever (100%) and cough (60%) were the most common symptoms in patients. All patients used standard immunosuppressive drugs (tacrolimus, corticosteroids, mycophenolate, and cyclosporine). The mean level of oxygen saturation at the time of admission in these patients was 87.9±11.3 and in two patients with death outcomes of 57% and 95%, it was at the beginning of hospitalization. The mean leukocytes of patients at the beginning of hospitalization was10470±5784.08 per ml and the mean lymphocytes of these patients were 1081.5±516.05. In the studied patients, the mean of previous years of transplantation was 8/05±7.13 and two patients died 20 years and 5 years after their kidney transplantation. Two patients (20%), aged 57 and 50 years, died from progressive respiratory symptoms and the other eight patients recovered and were discharged from the hospital.
We reported COVID-19 infection in ten kidney transplant recipients with different clinical outcomes and periods, which may be a reference for the management of COVID-19 in such patients.
Conclusion: It seems that more information is needed to better understand the effect of anti-transplant immunosuppressive therapy on the outcome of COVID-19 infection in kidney transplant recipients. Long-term follow-up studies and more cases are needed to clarify the diagnosis, outcome, and treatment options for COVID-19 in these patients.
Type of Study: Case Report |
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
